TRGM (Targeted Medical Pharma) Cash And Cash Equivalents : $0.08 Mil (As of Dec. 2015)

View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma Cash And Cash Equivalents?

Targeted Medical Pharma's quarterly cash and cash equivalents stayed the same from Jun. 2015 ($0.02 Mil) to Sep. 2015 ($0.02 Mil) but then increased from Sep. 2015 ($0.02 Mil) to Dec. 2015 ($0.08 Mil).

Targeted Medical Pharma's annual cash and cash equivalents declined from Dec. 2013 ($0.49 Mil) to Dec. 2014 ($0.01 Mil) but then increased from Dec. 2014 ($0.01 Mil) to Dec. 2015 ($0.08 Mil).

Targeted Medical Pharma Cash And Cash Equivalents Historical Data

The historical data trend for Targeted Medical Pharma's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Targeted Medical Pharma Cash And Cash Equivalents Chart

Targeted Medical Pharma Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.15

0.33

0.49

0.01

0.08

Targeted Medical Pharma Quarterly Data
	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15
Cash And Cash Equivalents	Get a 7-Day Free Trial															0.01	0.22	0.02	0.02	0.08

Targeted Medical Pharma Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Targeted Medical Pharma (OTCPK:TRGM) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Targeted Medical Pharma Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Targeted Medical Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077

Website

http://www.tmedpharma.com

Targeted Medical Pharma Inc is a medical nutrition company that develops amino acid based medical foods and other oral nutrition products for the long term management of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep, respiratory disorders, allergies and cognitive disorders.

Executives

William B. Horne	officer: Chief Financial Officer	C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald	director	C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb	director	MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph	officer: See Remarks	C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour	director, 10 percent owner, officer: Former President	C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher	director	12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke	officer: Chief Financial Officer	C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc	10 percent owner, other: Former 10% Owner	269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel	director, officer: Vice President	16178 EAST PRETENCE PLZ, AURORA CO 80015

Targeted Medical Pharma Headlines

No Headlines